Monday, May 05, 2014 11:38:43 AM
US Patent for PD Treatment of PD
WO/2014/066686 - BRAIN TARGETS FOR NEUROTROPHIC FACTORS TO TREAT NEURODEGENERATIVE DISEASE 01.05.2014 A61K 38/18
PCT/US2013/066688 AMARANTUS BIOSCIENCE HOLDINGS, INC. COMMISSIONG, John, W.
http://patentscope.wipo.int/search/en/detail.jsf?docId=WO2014066686&recNum=1&maxRec=10&office=&prevFilter=&sortOption=Pub+Date+Desc&queryString=FP%3A%28commissiong%29&tab=PCTDescription
International application for MANF for PD status as of 5/5/2014
http://patentscope.wipo.int/search/iasr?ia=US2013066688&PAGE=HTML&ACCESS=screen&TOK=YUbO3Yw_Xe7rLOU1IwwOS8siUHQ
FEATURED Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • Jun 14, 2024 2:07 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM